Citizens for Consume, et al v. Abbott Laboratories,, et al

Track this case

Case overview

Case Number:

1:01-cv-12257

Court:

Massachusetts

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action

Judge:

Patti B. Saris

Firms

Companies

Government Agencies

Sectors & Industries:

  1. July 10, 2007

    AstraZeneca, Bristol-Myers Oppose "Do Over"

    AstraZeneca LP and Bristol Myers-Squibb Co. have asked a judge to reject plaintiffs' request that the court award them an additional year's worth of damages, pointing out that the group's earlier quest to prove the degree of alleged harm had already failed.

  2. July 06, 2007

    Wholesale Price Plaintiffs Call Damages Incomplete

    After winning damages for harm suffered from 1997 through 2002 in a massive antitrust class action against several pharmaceutical giants, plaintiffs asked the court Thursday to award damages for 2003 as well, though there is no hard data showing harm in that year.

  3. June 29, 2007

    Dey Buries Hatchet With States In Drug Pricing Suit

    The states of Montana and Nevada have reached a settlement with Dey Inc., one of a slew of pharmaceutical companies involved in a massive antitrust class action alleging that the companies defrauded consumers by artificially inflating the prices of various prescription drugs.

  4. June 21, 2007

    Judge Finds Drug Makers Liable For Inflating Costs

    A federal judge has issued a stinging rebuke to three pharmaceutical companies in a massive antitrust class action, finding that they acted unfairly and deceptively by causing the publication of artificially inflated average wholesale prices for various prescription drugs.

  5. June 20, 2007

    Plaintiffs Win More Time To Seal Glaxo Deal

    The plaintiffs in an antitrust class action alleging that a slew of pharmaceutical companies defrauded consumers by artificially inflating the prices of various prescription drugs have received more time to finalize a settlement with GlaxoSmithKline plc.

  6. November 03, 2006

    Pharmaceutical Giants, Consumers Spar As Trial Looms

    On the eve of trial, a federal judge has clarified the definition of a term at the center of an antitrust class action lawsuit alleging that a slew of pharmaceutical companies defrauded consumers by artificially inflating the prices of various prescription drugs.

  7. September 11, 2006

    DOJ Joins Whistleblower Suit Against Merck Affiliate

    The U.S. Department of Justice said Monday that it has intervened in a whistleblower lawsuit accusing generic drug maker Dey Inc., an affiliate of German pharmaceutical company Merck KGaA, of engaging in a fraudulent scheme to overcharge federal health care programs.